National Institute for Health and Clinical Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Review of technology appraisal 98. Available at: www.nice.org.uk/TA98 [accessed August 2017].
Diagnostic and Statistical Manual of mental disorders - Fifth Edition American Psychiatric Association, 2013.
Scottish Intercollegiate Guidelines Network. Management of attention deficit and hyperkinetic disorders in children and young people: a national clinical guideline. Guideline 112; October 2009. Available at: http://www.sign.ac.uk/assets/sign112.pdf [accessed August 2017].
Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997;36: 1036-45.
Nutt DJ, et al. Evidence-based guidelines for management of attention-deficit/ hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2007;21(1): 10-41.
Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/ hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-1323.
Castellanos FX, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288(14): 1740-8.
Valera EM, et al. Meta-analysis of structural imaging findings in attention-deficit/ hyperactivity disorder. Biol Psychiatry 2007; 61(12): 1361-9.
Spencer TJ, et al. Overview and neurobiology of ADHD. J Clinical Psych 2002; 63(S12): 3-9.
Gillberg C, et al. Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 2004; 13(Suppl 1):I80-92.
Thompson AE, et al. Children with ADHD transferring to secondary school: Potential difficulties and solutions. Clinical Child Psychology and Psychiatry 2003;8(1): 91-103.
All Party Parliamentary Group for Children (APPGC). `Every Child Matters` Green Paper. September 2003.
ADHD is an abbreviation for Attention Deficit Hyperactivity Disorder. The information provided on this website is not a substitute for professional medical care. As always if you have any concerns about you or your child’s health or medication you should consult your specialist or general practitioner. This site is published by Janssen-Cilag Limited, which is solely responsible for the content. It is intended for a UK audience.